Skip to main content

Animations

MJFF Publications

6681 - 6690 of 9145 Results
Title
Year
  • Year
  • 2019
  • 2018
  • 2023
  • 2025
  • 2020
  • 2008
  • 2016
  • 2017
  • 2022
  • 2023
  • Summary Details
    OPEN
    Title: Transportation innovation to aid Parkinson disease trial recruitment
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 gene encoding Miro1
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.scr.2023.103145
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Attenuated neurotoxicity after repeated methamphetamine binges linked to dopamine transporter (DAT) decline
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106839
    Citation Count: 4
  • Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    2020
    Summary Details
    RESTRICTED
    Title: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914
    Citation Count: 22
  • Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging
    2008
    Summary Details
    RESTRICTED
    Title: Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.12.004
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.07.013
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awx285
    Citation Count: 452
  • Summary Details
    OPEN
    Title: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-07706-2
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Sex differences in associations between APOE ε2 and longitudinal cognitive decline
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.13036
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.